Earnings Feed
Start Free
Phathom Pharmaceuticals, Inc.·4

Mar 3, 5:11 PM ET

Breedlove Robert Charles 4

Research Summary

AI-generated summary

Updated

Phathom (PHAT) Principal Accounting Officer Robert Breedlove Receives Awards

What Happened

  • Robert Charles Breedlove, Phathom's Principal Accounting Officer, was granted/issued equity on Feb 27, 2026 and also surrendered shares to cover withholding. He was granted 13,000 restricted stock units (RSUs) (award code A) and received 2,790 shares issued upon vesting of previously granted performance stock units (PSUs). To satisfy tax withholding, Breedlove surrendered a total of 1,378 shares (964 shares and 414 shares) which were treated as dispositions at $12.56 per share, generating proceeds of $12,108 and $5,200 respectively (total ~$17,308). The primary activity here is an equity award/vesting, with the share surrenders representing tax withholding rather than an open-market sale.

Key Details

  • Transaction date: February 27, 2026; Form 4 filed March 3, 2026 (filed within the typical two-business-day window).
  • Grants/issuances: 13,000 RSUs (new grant) and 2,790 shares issued upon PSU vesting.
  • Tax withholding dispositions: 964 shares and 414 shares surrendered at $12.56 per share (total surrendered = 1,378 shares; total ~$17,308).
  • Shares owned after the transaction: not specified in the provided filing excerpt.
  • Footnotes of note:
    • F1: The 13,000 RSUs vest 1/3 on each of the first three anniversaries of Feb 27, 2026, subject to continued service; each RSU equals one share on vesting.
    • F2: The 2,790 shares represent PSUs granted Feb 27, 2025 that were determined to have met performance criteria and vested Feb 27, 2026.
    • F3/F4: The surrendered shares were delivered to the issuer to satisfy the issuer's tax withholding obligations (i.e., tax withholding, not an open-market sale).
  • Transaction codes: A = Award/Grant; F = tax withholding disposition.

Context

  • This filing shows equity compensation being granted and vested (a common retention/compensation mechanism). The surrendered shares solely cover tax obligations and do not necessarily indicate a decision to sell shares for investment reasons. For RSUs, vesting is time-based (1/3 per year); for PSUs, vesting depended on prior performance metrics that were determined satisfied.